Correction to: Anti-migraine agents from an immunological point of view

Correction to: Anti-migraine agents from an immunological point of view

Bibliographic Details
Main Author:	Mushref Bakri Assas
Format:	Article
Language:	English
Published:	BMC 2021-08-01
Series:	Journal of Translational Medicine
Online Access:	https://doi.org/10.1186/s12967-021-02988-y

Similar Items

Anti-migraine agents from an immunological point of view
by: Bakri M. Assas
Published: (2021-01-01)

Author Correction: Early induction of C/EBPβ expression as a potential marker of steroid responsive colitis
by: Mushref Bakri Assas, et al.
Published: (2021-08-01)

Vestibular migraine: Considered from both the vestibular and the migraine point of view
by: Gulden Akdal, et al.
Published: (2020-01-01)

Inhibition of gap junctional intercellular communication by an anti-migraine agent, flunarizine.
by: Joo Hye Yeo, et al.
Published: (2019-01-01)

Causation and the Agent’s Point of View
by: Sebastián Álvarez
Published: (2014-02-01)

<it>Immunity & Ageing</it>: a new journal looking at ageing from an immunological point of view
by: Caruso Calogero, et al.
Published: (2004-10-01)

CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
by: Valentina Favoni, et al.
Published: (2019-03-01)

Possible Transmission of Zoonoses in Xenotransplantation: Porcine Endogenous Retroviruses (PERVs) from an Immunological Point of View
by: Blomberg Jonas, et al.
Published: (2004-03-01)

Chocolate is a Migraine-Provoking Agent
by: J Gordon Millichap
Published: (1991-07-01)

A Bidirectional View of Migraine and Diet Relationship
by: Gazerani P
Published: (2021-02-01)

Abscopal Effect Following Radiation Therapy in Cancer Patients: A New Look from the Immunological Point of View
by: J Welsh, et al.
Published: (2020-08-01)

Correctly grasp the diagnosis of vestibular migraine
by: Yan-sheng LI, et al.
Published: (2019-01-01)

The ranking of multiattribute alternatives : moral dilemmas from the agent's point of view /
by: Aronson, Kristin
Published: (1983)

Emotional impairments and their correction in patients with migraine
by: L S Chutko, et al.
Published: (2017-04-01)

Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
by: Mark E. Bangs, et al.
Published: (2020-03-01)

Preventive Agents for Migraine: Focus on the Antiepileptic Drugs
by: R. Shahien, et al.
Published: (2012-02-01)

Preventive Agents for Migraine: Focus on the Antiepileptic Drugs
by: R. Shahien, et al.
Published: (2012-04-01)

The impact of midlife on migraine in women: summary of current views
by: Jelena M. Pavlović
Published: (2020-10-01)

Migraine: modern view of the classification, pathophysiology and specific therapy
by: Y. E. Azimova
Published: (2014-12-01)

A Ciliary View of the Immunological Synapse
by: Chiara Cassioli, et al.
Published: (2019-07-01)

Developments in Bovine Immunology - An Integrated View
Published: (2015)

Myofascial trigger points in migraine and tension-type headache
by: Thien Phu Do, et al.
Published: (2018-09-01)

Observations on the immunological and non-immunological anti-tumour effects of swainsonine
by: Galustian, Christine
Published: (1996)

From a Philosophical point of view, can the Budism Be An Anti-Sacrificial Science?
by: Francisco Felizol Marques
Published: (2014-04-01)

From Her Point of View : Woman's Anti-World in the Poetry of Anna Świrszczyńska
by: Ingbrant, Renata
Published: (2007)

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents
by: Maurizio Pompili, et al.
Published: (2010-09-01)

Prophylactic treatment of migraine; the patient's view, a qualitative study
by: Dekker Frans, et al.
Published: (2012-03-01)

Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
by: Michael Ament, et al.
Published: (2021-08-01)

Immunological Agents Used in Cancer Treatment
by: Melih Simsek, et al.
Published: (2019-02-01)

Encounters with Immunologic Agents in General Practice
by: Patel, N., et al.
Published: (2016)

The Performance of Management and The Workplace Experience of Employee of Correction Agency – From The Point of View of CSR
by: Lin,Ming-Shih, et al.
Published: (2016)

Migraine strikes as neuronal excitability reaches a tipping point.
by: Marten Scheffer, et al.
Published: (2013-01-01)

Early induction of C/EBPβ expression as a potential marker of steroid responsive colitis
by: Bakri M. Assas, et al.
Published: (2019-09-01)

RNase T2 in Inflammation and Cancer: Immunological and Biological Views
by: Lei Wu, et al.
Published: (2020-08-01)

Understanding ageing: Biomedical and bioengineering approaches, the immunologic view
by: Vasto Sonya, et al.
Published: (2008-09-01)

An Analysis of Anti-corruption Campaign in Taiwan: A Global Point of View
by: 黃建國
Published: (2015)

Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine
by: Julia Pakpoor, et al.
Published: (2013-01-01)

Correction to: Therapeutic novelties in migraine: new drugs, new hope?
by: Thien Phu Do, et al.
Published: (2019-05-01)

Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
by: Julia Pakpoor, et al.
Published: (2013-01-01)

Correction: Selectivity in Genetic Association with Sub-classified Migraine in Women.
by: Daniel I Chasman, et al.
Published: (2015-06-01)

Cannot write session to /tmp/vufind_sessions/sess_q79d17qnm2panmiilj27t712mn